{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:09:03Z","timestamp":1793372943804,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.curtheres.2024.100740","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T17:03:16Z","timestamp":1709139796000},"page":"100740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye Infections"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-5497","authenticated-orcid":false,"given":"Valentina","family":"Gentili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Strazzabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Spena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-9265","authenticated-orcid":false,"given":"Silvia","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Schiuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9507-9126","authenticated-orcid":false,"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.curtheres.2024.100740_bib0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00003226-199801000-00013","article-title":"In vitro antibiotic susceptibilities of ocular isolates in North and South America","volume":"17","author":"Jensen","year":"1998","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100740_bib0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/eye.1995.17","article-title":"Toxicity of antibiotics and antifungals on cultured human corneal cells: Effect of mixing, exposure and concentration","volume":"9","author":"Berry","year":"1995","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.curtheres.2024.100740_bib0003","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/antibiotics10080964","article-title":"Moxifloxacin and sulfamethoxazole-based nanocarriers exhibit potent antibacterial activities","volume":"10","author":"Akbar","year":"2021","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100740_bib0004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/jac\/dkl356","article-title":"Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model","volume":"58","author":"Odenholt","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.curtheres.2024.100740_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/psb.882","article-title":"Moxifloxacin: new fluoroquinolone for bacterial conjunctivitis","volume":"23","author":"Chaplin","year":"2012","journal-title":"Prescriber"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100740_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ICU.0000000000000727","article-title":"Endophthalmitis after cataract surgery: an update on recent advances","volume":"32","author":"Peck","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.curtheres.2024.100740_bib0007","first-page":"44","article-title":"Topical chloramphenicol for eye infections","volume":"8","author":"Lam","year":"2002","journal-title":"Hong Kong Med J"},{"issue":"13","key":"10.1016\/j.curtheres.2024.100740_bib0008","first-page":"1313","article-title":"Chloramphenicol toxicity: a review","volume":"2","author":"Shukla","year":"2011","journal-title":"Journal of Medicine and Medical Sciences."},{"issue":"9","key":"10.1016\/j.curtheres.2024.100740_bib0009","article-title":"Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota","volume":"7","author":"Lorenzo","year":"2019","journal-title":"Microorganisms"},{"issue":"Pt 5","key":"10.1016\/j.curtheres.2024.100740_bib0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/eye.1998.221","article-title":"Lack of evidence for systemic toxicity following topical chloramphenicol use","volume":"12","author":"Walker","year":"1998","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100740_bib0011","first-page":"3","article-title":"Safety of chloramphenicol eyedrops","volume":"25","author":"Firkin","year":"1997","journal-title":"Aust N Z J Ophthalmol"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100740_bib0012","article-title":"Antibiotic prophylaxis for corneal abrasion","volume":"5","author":"Algarni","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100740_bib0013","first-page":"105","article-title":"The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of silver nanoparticles against Staphylococcus aureus","volume":"7","author":"Parvekar","year":"2020","journal-title":"Biomater Investig Dent"},{"issue":"27","key":"10.1016\/j.curtheres.2024.100740_bib0014","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302367120","article-title":"Activated alkyne-enabled turn-on click bioconjugation with cascade signal amplification for ultrafast and high-throughput antibiotic screening","volume":"120","author":"Lv","year":"2023","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.curtheres.2024.100740_sbref0015","series-title":"Clinical breakpoints","year":"2023"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100740_bib0016","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.1038\/s41598-018-28842-8","article-title":"Inhibition and Eradication of Pseudomonas aeruginosa Biofilms by Host Defence Peptides","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100740_bib0017","doi-asserted-by":"crossref","first-page":"M1299","DOI":"10.1111\/1750-3841.12902","article-title":"Inhibition of Gallic Acid on the Growth and Biofilm Formation of Escherichia coli and Streptococcus mutans","volume":"80","author":"Shao","year":"2015","journal-title":"J Food Sci"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100740_bib0018","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002018-199308050-00004","article-title":"Systemic and local tolerability of ophthalmic drug formulations","volume":"8","author":"Hugues","year":"1993","journal-title":"Drug Saf"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:28:49Z","timestamp":1730975329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":18,"alternative-id":["S0011393X24000109"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100740","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye Infections","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100740"}}